Brainstorm cell therapeutics to host investor call and provide a corporate update

Call scheduled for december 30, 2024, at 8:30 am et; additionally, key opinion leader webinar on als advancements to take place on december 11, 2024 new york , dec. 9, 2024 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a conference call and webcast on december 30, 2024, at 8:30 a.m. eastern time.
BCLI Ratings Summary
BCLI Quant Ranking